Akebia Therapeutics (AKBA) Selling, General & Administrative (2013 - 2026)
Akebia Therapeutics (AKBA) Selling, General & Administrative (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 304.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 588.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 5.21 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 184.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 928.80 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 318.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 381.00 Mn |
| 10 | Akebia Therapeutics | 325.80 Mn | 163.20 Mn | 41.25 Mn | 30.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30.44 Mn |
| Dec 31, 2025 | 26.09 Mn |
| Sep 30, 2025 | 29.09 Mn |
| Jun 30, 2025 | 26.56 Mn |
| Mar 31, 2025 | 25.74 Mn |
| Dec 31, 2024 | 27.68 Mn |
| Sep 30, 2024 | 26.52 Mn |
| Jun 30, 2024 | 26.92 Mn |
| Mar 31, 2024 | 25.44 Mn |
| Dec 31, 2023 | 25.44 Mn |
| Sep 30, 2023 | 22.71 Mn |
| Jun 30, 2023 | 27.04 Mn |
| Mar 31, 2023 | 25.05 Mn |
| Dec 31, 2022 | 29.91 Mn |
| Sep 30, 2022 | 31.89 Mn |
| Jun 30, 2022 | 32.24 Mn |
| Mar 31, 2022 | 44.57 Mn |
| Dec 31, 2021 | 44.80 Mn |
| Sep 30, 2021 | 46.36 Mn |
| Jun 30, 2021 | 41.65 Mn |